# Cilostazol

NDC: 0093-2065
Generic name: Cilostazol
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20120424

FDA application: ANDA077027

## Active ingredients

- CILOSTAZOL: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-2065"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-2065
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6292311-9cb2-49ff-b8bf-12e2dbd196cd